Media and Investors Resources

Press Release, 15 July 2021

Adhoc Press Release

Kuros to receive $7 million up front and potentially $166.5 million in future revenues under a royalty purchase agreement with XOMA related to Kuros’s license agreement with Checkmate Pharmaceuticals

Minutes of the AGM, 19 April 2021

German version

Press Release, 22 June 2021

Kuros Biosciences announces publication of data on MagnetOs in eCM Journal linking MOA to enhanced predictable bone regeneration

Press Release, 17 June 2021

Kuros Biosciences to present at upcoming U.S. spine conferences

Press Release, 2 June 2021

Kuros Biosciences’s commercial roll-out of MagnetOs bone graft exceeds expectations

Press Release, 17 May 2021

Kuros to receive $4 million milestone payment from Checkmate Pharmaceuticals